Full Agenda (subject to change)

Speaker: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Emanuela M. Ghia, PhD – Center for Novel Therapeutics; University of California, San Diego

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno

Co-Chair: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London

Co-Chair: Philip Thompson, MB, BS (Hons) – Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Erin M. Parry, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Moritz Fürstenau, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

Co-Chair: Elżbieta Iskierka-Jażdżewska, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland

Co-Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno